Skip to main content
Log in

Medicinal chemistry

New lead for pain treatment

  • News & Views
  • Published:

From Nature

View current issue Submit your manuscript

The synthesis of conolidine, a scarce, naturally occurring compound, has enabled the first studies of its pharmacological properties to be carried out. Excitingly, conolidine is a painkiller that seems to have an unusual mechanism of action.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Figure 1: Inspiration for the synthesis of conolidine.

References

  1. Tarselli, M. A. et al. Nature Chem. 3, 449–453 (2011).

    Article  ADS  CAS  Google Scholar 

  2. Kam, T.-S., Pang, H.-S., Choo, Y.-M. & Komiyama, K. Chem. Biodiver. 1, 646–656 (2004).

    Article  CAS  Google Scholar 

  3. Potier, P. & Janot, M. M. C.R. Acad. Sci. 276C, 1727 (1973).

    Google Scholar 

  4. Scott, A. I., Yeh, C.-L. & Greenslade, D. J. Chem. Soc. Chem. Commun. 947–948 (1978).

  5. Rice, K. C. in The Chemistry and Biology of Isoquinoline Alkaloids (eds Phillipson, J. D., Roberts, M. F. & Zenk, M. H.) 191–203 (Springer, 1985).

    Book  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Sarah E. Reisman.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Reisman, S. New lead for pain treatment. Nature 473, 458–459 (2011). https://doi.org/10.1038/473458a

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/473458a

  • Springer Nature Limited

This article is cited by

Navigation